ArticleScientific reports2026
sc-eQTL unveil immunogenetic architecture of polycystic ovary syndrome.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multi-omics-driven precision medicine.iMeta · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by metabolic, inflammatory, and reproductive dysfunction. We integrated genome-wide association study (GWAS) data, and single-cell expression quantitative trait loci (sc-eQTL) across various immune cells to elucidate the genetic and immune mechanisms underlying PCOS at the cellular level. Finally, we identified 19 risk loci for PCOS, prioritizing 16 candidate causal genes, approximately 30% of these genes are immune-related. Pathway analysis revealed 15 PCOS-associated signaling pathways, spanning hormonal regulation and immune function, notably T cell-mediated responses. Single-cell RNA sequencing analysis implicated NK cells, CD8 T cells, and CD4 T cells play a crucial role in PCOS pathogenesis, with the highest trait-relevant scores. sc-eQTL colocalization analysis identified IRF1 and MAPRE1 as causal genes with regulatory effects in specific T cell subsets and NK cells, which were obscured by bulk eQTL analysis. Moreover, MAPRE1 showing a discordant effect in NK cells, suggesting immune dysregulation. Our findings underscore the pivotal roles of metabolic and immune-related genes in PCOS and the importance of immune cell-specific mechanisms, enhancing our understanding of its pathophysiology and potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.